ARMISTICE CAPITAL, LLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 162 filers reported holding CLOVIS ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
ARMISTICE CAPITAL, LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q4 2020$10,829,000
+0.5%
2,256,000
+22.1%
0.37%
-5.9%
Q3 2020$10,774,000
-0.2%
1,848,000
+15.5%
0.39%
-17.5%
Q2 2020$10,800,000
+37.4%
1,600,000
+7900.0%
0.47%
-9.0%
Q3 2019$7,860,000
-76.1%
20,000
-99.1%
0.52%
-74.9%
Q2 2019$32,946,000
-36.8%
2,215,600
+5.5%
2.08%
-27.2%
Q1 2019$52,122,000
-42.4%
2,100,000
-58.3%
2.85%
-58.4%
Q4 2018$90,447,000
+88.2%
5,036,000
+207.8%
6.86%
+137.7%
Q3 2018$48,049,000
+69.3%
1,636,000
+162.2%
2.88%
+55.6%
Q2 2018$28,373,000
+14.8%
624,000
+33.3%
1.85%
-2.0%
Q1 2018$24,710,000468,0001.89%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q4 2019
NameSharesValueWeighting ↓
Coppell Advisory Solutions LLC 229$11,0080.00%
View complete list of CLOVIS ONCOLOGY INC shareholders